Author: Lynne Taylor

98.9% of US oncologists polled for a recent survey say they have experienced shortages of cancer drugs in the last year, and that as a result of the shortages, cancer has progressed in more than 60% of their patients.

The patient voice in the assessment of value of medicines needs to be louder than it is at present, but the pricing of medicines “has to remain the absolute domain of companies,” the Association of the British Pharmaceutical Industry (ABPI) has stated.

US biopharmaceutical research companies are currently developing a total of 221 new medicines for the treatment of diabetes and related conditions, according to new industry data.

Many New Zealanders are not getting free prescription medicines when they should, new research has found.

A coalition of leading UK cancer charities has criticised the government for “shutting patients out of crucial talks” on the proposed value-based pricing (VBP) arrangements for new drugs.